1. Home
  2. VHC vs LSTA Comparison

VHC vs LSTA Comparison

Compare VHC & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VirnetX Holding Corp

VHC

VirnetX Holding Corp

HOLD

Current Price

$18.43

Market Cap

79.2M

Sector

Miscellaneous

ML Signal

HOLD

Logo Lisata Therapeutics Inc.

LSTA

Lisata Therapeutics Inc.

HOLD

Current Price

$2.05

Market Cap

20.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VHC
LSTA
Founded
2005
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Multi-Sector Companies
Misc Health and Biotechnology Services
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
79.2M
20.9M
IPO Year
1999
N/A

Fundamental Metrics

Financial Performance
Metric
VHC
LSTA
Price
$18.43
$2.05
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$23.50
AVG Volume (30 Days)
22.9K
23.6K
Earning Date
11-14-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$106,000.00
$1,070,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2020.00
N/A
52 Week Low
$3.87
$1.81
52 Week High
$29.00
$4.20

Technical Indicators

Market Signals
Indicator
VHC
LSTA
Relative Strength Index (RSI) 45.20 47.86
Support Level $16.32 $2.00
Resistance Level $19.16 $2.17
Average True Range (ATR) 1.81 0.10
MACD -0.18 0.02
Stochastic Oscillator 35.46 52.00

Price Performance

Historical Comparison
VHC
LSTA

About VHC VirnetX Holding Corp

VirnetX Holding Corp is engaged in the business of commercializing a portfolio of patents. It is an Internet security software and technology company with patented technology for secure communications. The company's software and technology solutions, including its Secure Domain Name Registry and Technology, VirnetX One, War Room, VirnetX Matrix, and GABRIEL Connection Technology, are designed to be device and location-independent, and enable a secure real-time communication environment for all types of enterprise applications, services and critical infrastructures.

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.

Share on Social Networks: